-
1 Comment
BiomX Inc is currently in a long term downtrend where the price is trading 9.4% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
BiomX Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 57.0% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 61.7% to $-7M since the same quarter in the previous year.
Based on the above factors, BiomX Inc gets an overall score of 3/5.
| CurrencyCode | USD |
|---|---|
| ISIN | US09090D1037 |
| Exchange | AMEX |
| Sector | Industrials |
| Industry | Aerospace & Defense |
| Beta | 1.19 |
|---|---|
| Market Cap | 8M |
| PE Ratio | None |
| Target Price | 304 |
| Dividend Yield | None |
BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PHGE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026